Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

#38–Francisco Gonzalez-Lima, Ph.D.: Alzheimer’s disease & the vascular hypothesis

Original release date: 1/28/18 In this episode, Francisco Gonzalez-Lima, a Professor of Neuroscience and Pharmacology & Toxicology, explains the vascular hypothesis of Alzheimer’s disease which says the central problem is a progressive neuronal energy crisis of impaired blood flow to the brain and impaired mitochondrial respiration. He walks us through the ways we can intervene in this process and also shares details of the exciting future of Alzheimer’s treatment and prevention. We discuss: -Background and interest in the brain [5:15]; -The unique nature of the human brain [9:15]; -Why we’ve made so little progress in Alzheimer’s research [23:00]; -The amyloid beta hypothesis [28:30]; -Hypometabolism in the brain leading to cognitive decline [39:30]; -Early signs of AD, and deciphering between age-related decline versus something pathologic [47:45]; -The vascular hypothesis of Alzheimer’s disease [54:00]; -The relationship between mitochondria, cytochrome c oxidase, and Alzheimer’s disease [1:08:00]; -Chronic inhibition of cytochrome c oxidase leads to chronic neurodegenerative disease [1:22:45]; -Major risk factors for AD, head trauma, and other forms of dementia [1:33:45]; -Methylene blue for treating and preventing neurodegeneration [1:38:15]; -Current standard of care for AD, and the reasons for a lack of advancement [2:01:45]; -Near infrared light as a targeted treatment for cognitive decline [2:05:30]; -The ketogenic diet as a treatment and preventative measure [2:13:15]; -Exciting future research coming from Francisco [2:13:00]; -Methylene blue for traumatic brain injuries [2:25:15]; and -More. Show notes page: https://peterattiamd.com/franciscogonzalezlima/ About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 10 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. The practice applies nutritional biochemistry, exercise physiology, sleep physiology, techniques to increase distress tolerance, lipidology, pharmacology, and four-system endocrinology to increase lifespan (delaying the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com/ Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Play: http://bit.ly/TheDriveGooglePlay

Peter AttiahostFrancisco Gonzalez-Limaguest
Jan 7, 20202h 32mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Alzheimer's as an Energy Crisis: Vascular Hypothesis and Mitochondrial Fixes

  1. Gonzalez-Lima contends that early-onset familial Alzheimer's and the far more common late-onset dementia are different diseases, and that the amyloid-driven research model built on the early-onset case has failed for the late-onset form.
  2. He describes chronic cerebral hypoperfusion from arterial stiffening, intimal thickening and the capillary damage caused by compensatory high blood pressure as a driver that downregulates cytochrome c oxidase and starves neurons of energy.
  3. His own work found inhibited cytochrome oxidase in fresh Alzheimer's brains, and animal models in which partial vessel occlusion or low-dose azide impair memory support the energy-crisis idea.
  4. He presents three ways to boost mitochondrial respiration: low-dose methylene blue as an electron cycler, transcranial 1064 nm near-infrared laser light aimed at the prefrontal cortex, and ketones or periodic fasting.
  5. He also criticizes current drugs and trials, saying cholinesterase inhibitors and memantine are ineffective, the LMTM trial was framed around a wrong anti-tau hypothesis, and unpatentable methylene blue gets little industry or NIH investment.

IDEAS WORTH REMEMBERING

5 ideas

Alzheimer's may be two diseases under one name

Gonzalez-Lima says the 1907 case was a young, likely familial patient, while about nine in ten cases are late-onset with no inheritance, so models built on the early-onset form do not apply.

Amyloid deposition does not track dementia in late-onset cases

He says pathologists could not tell brains of cognitively normal people from those diagnosed with Alzheimer's, and he argues amyloid is not causal in late-onset disease, though it plays a role in early-onset cases.

Chronic hypoperfusion is distinct from stroke

Gonzalez-Lima describes a slow, indolent loss of blood supply, roughly 20% between ages 22 and 60, linked to carotid intima-media thickness and to cognitive decline in a linear relationship.

Complex IV is a vulnerable, inducible bottleneck

Cytochrome c oxidase is the rate-limiting, on-demand enzyme that drops with hypoxia, and he found it inhibited rather than depleted in Alzheimer's brains, which is potentially reversible.

The brain is especially exposed to energy failure

Attia notes the brain is about 2% of body weight but uses about 20% of energy, and Gonzalez-Lima adds that neurons lack significant alternative ATP routes, so cognitive deficits appear first.

WORDS WORTH SAVING

5 quotes

We have not made any significant progress in Alzheimer's disease research. This is the largest failure of the biomedical research enterprise in the world during my lifetime.

— Francisco Gonzalez-Lima

I would say is the key to aerobic life on the planet.

— Francisco Gonzalez-Lima

The brain is more of an electrical engineer where you have lots of circuits. And the liver, for that matter, will be a chemical engineer where we break down all of these substances that the body consumes.

— Francisco Gonzalez-Lima

Their results do not support the hypothesis, and they keep blindly moving forward.

— Francisco Gonzalez-Lima

I'm not sure how you can trust me if I'm telling you about something when you know I'm being paid by the company that makes it to tell you about it.

— Peter Attia

Early-onset versus late-onset Alzheimer'sCritique of the amyloid hypothesisChronic cerebral hypoperfusion and vascular healthCytochrome c oxidase and mitochondrial respirationMethylene blue history and dosingTranscranial near-infrared light therapyKetones, fasting and brain glucose uptake

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.